Identification of a novel mutation in CYBB gene in a Chinese neonate with X-linked chronic granulomatous disease A case report

Rationale: X-linked chronic granulomatous disease (X-CGD) is an X-linked recessive disorder of the Nicotinamide adenine dinucleotide phosphate oxidase system that can cause primary immunodeficiency. Mutations in the CYBB gene located in Xp21.1 were accounting for X-CGD disease. More than 600 mutations have been identified as the cause of X-CGD in various populations worldwide. Patient concerns and diagnosis: In this study, the proband suffered from elevated white blood cells (WBC, 23.65 x 109/L), mainly in neutral (16.4 x 109/L). The neutrophil oxidative index of the patient was 2.13, which was extremely low, whereas his mother was 69.0 (Ref >100). Next, next-generation sequencing of the primary immunodeficiency diseases -related gene panel was performed. One novel mutation was identified in the CYBB gene in the CGD case: c.55C>G in exon 2. The mutation was verified by Sanger sequencing. The mother of the patient was heterozygous for the c.55C>G mutation, and the father was normal. These mutations were not present in the 100 unrelated normal controls. Interventions and outcomes: The patient died from severe and uncontrollable pulmonary infection at 3 months of age. Lessons: The identification of these mutations in this study further expands the spectrum of known CYBB gene mutations and contributes to the genetic counseling and prenatal molecular diagnosis of X-CGD.

Automated summary

In this study, a novel mutation in the CYBB gene was identified in a patient with X-linked chronic granulomatous disease, expanding the knowledge of mutation spectrum. This finding contributes to genetic counseling and prenatal molecular diagnosis of X-CGD.